Team:Stockholm/5 July 2010
From 2010.igem.org
m |
m |
||
(4 intermediate revisions not shown) | |||
Line 2: | Line 2: | ||
__TOC__ | __TOC__ | ||
- | = | + | = Andreas = |
+ | |||
+ | === Plasmid preparations === | ||
+ | Prepared plasmids from ON cultures. | ||
+ | |||
+ | '''DNA concentrations''' | ||
+ | {|border="1" cellspacing="0" cellpadding="2" | ||
+ | |'''Sample''' | ||
+ | |'''DNA conc (ng/ul)''' | ||
+ | |'''A<sub>260</sub>/A<sub>280</sub>''' | ||
+ | |- | ||
+ | |pSB1A3.BBa_J04450 | ||
+ | |66.8 | ||
+ | |1.74 | ||
+ | |- | ||
+ | |pSB1C3.BBa_J04450 | ||
+ | |36.5 | ||
+ | |1.87 | ||
+ | |- | ||
+ | |pSB1AC3.BBa_J04450 | ||
+ | |41.0 | ||
+ | |1.95 | ||
+ | |- | ||
+ | |pSB1AK3.BBa_J04450 | ||
+ | |10.8 | ||
+ | |2.64 | ||
+ | |- | ||
+ | |pMA.BBa_J18930 | ||
+ | |33.3 | ||
+ | |1.95 | ||
+ | |- | ||
+ | |pMA.BBa_J18931 | ||
+ | |52.5 | ||
+ | |1.92 | ||
+ | |- | ||
+ | |pMA.BBa_J18932 | ||
+ | |34.1 | ||
+ | |1.99 | ||
+ | |} | ||
+ | |||
+ | === Part and primer design === | ||
+ | |||
+ | I investigated Mimmi's primers, most specifically the ones designed for ligation of our CPPs (TAT, LMWP and Transportan 10). Me and Johan discussed whether we should order them as is, or if we should instead have the genes synthesized. We decided that we should rethink the matter until tomorrow, when we can have a group meeting and discuss this further. | ||
+ | |||
+ | Johan also discovered that several of our genes contain disallowed BioBrick restriction sites: | ||
+ | * '''Tyrosinase''' contains one NgoMIV site at 500 bp. | ||
+ | * '''yCCS''' contains one EcoRI site at 230 bp. | ||
+ | * '''bFGF''' contains one AgeI site at 350 bp. | ||
+ | |||
+ | These need to be removed. We will discuss this tomorrow. | ||
+ | |||
+ | =Johan= | ||
+ | |||
+ | * PCR bFGF, 16 colonies | ||
+ | |||
+ | * gel | ||
+ | |||
+ | All bands too small (250) nt. After discussion with Rob we looked at the sequence and found that the gene has a AgeI restriction site. '''NOT GOOD''' | ||
+ | |||
+ | --- | ||
+ | |||
+ | * Transformation | ||
+ | |||
+ | bFGF vector (Amp resistance) from Japan into competent BL21 cells | ||
+ | |||
+ | 50 µl spreaded on one plate, 50 µl 10x dilution on one plate | ||
+ | |||
+ | {{Stockholm/Footer}} |
Latest revision as of 18:42, 27 October 2010
Contents |
Andreas
Plasmid preparations
Prepared plasmids from ON cultures.
DNA concentrations
Sample | DNA conc (ng/ul) | A260/A280 |
pSB1A3.BBa_J04450 | 66.8 | 1.74 |
pSB1C3.BBa_J04450 | 36.5 | 1.87 |
pSB1AC3.BBa_J04450 | 41.0 | 1.95 |
pSB1AK3.BBa_J04450 | 10.8 | 2.64 |
pMA.BBa_J18930 | 33.3 | 1.95 |
pMA.BBa_J18931 | 52.5 | 1.92 |
pMA.BBa_J18932 | 34.1 | 1.99 |
Part and primer design
I investigated Mimmi's primers, most specifically the ones designed for ligation of our CPPs (TAT, LMWP and Transportan 10). Me and Johan discussed whether we should order them as is, or if we should instead have the genes synthesized. We decided that we should rethink the matter until tomorrow, when we can have a group meeting and discuss this further.
Johan also discovered that several of our genes contain disallowed BioBrick restriction sites:
- Tyrosinase contains one NgoMIV site at 500 bp.
- yCCS contains one EcoRI site at 230 bp.
- bFGF contains one AgeI site at 350 bp.
These need to be removed. We will discuss this tomorrow.
Johan
- PCR bFGF, 16 colonies
- gel
All bands too small (250) nt. After discussion with Rob we looked at the sequence and found that the gene has a AgeI restriction site. NOT GOOD
---
- Transformation
bFGF vector (Amp resistance) from Japan into competent BL21 cells
50 µl spreaded on one plate, 50 µl 10x dilution on one plate